EBR Systems, Inc (EBRCZ) Fair Value & Analysis
Healthcare · US · Market cap $125M
Fair value as of: Jun 24, 2026
Analysis
EBR Systems, Inc (EBRCZ) currently trades at $0.3110, while our model-based Fair Value estimate is $0.1700 — implying the stock looks roughly 45.3% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is EBR Systems, Inc (EBRCZ) undervalued?
What is the fair value of EBRCZ?
What is the quality score of EBRCZ?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.